Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
[14C-ETC-1002]
Esperion Therapeutics
Hyperlipidemia
1 trial -
[14C] BIIB122 ([14C] DNL151)
Denali Therapeutics
Healthy Volunteers
1 trial -
[14C]-CORT113176
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
[14C]-CORT125134
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
[14C]-DNL343
Denali Therapeutics
Healthy Volunteers
1 trial -
[14C]-EDG-7500
Edgewise Therapeutics
Healthy Volunteer
1 trial -
[14C]-GSK961081 solution for IV infusion
Theravance Biopharma Ireland Umited
Pulmonary Disease, Chronic Obstructive
1 trial -
[14C]-Paxalisib Capsule
KAZIA THERAPEUTICS LTD
Healthy
1 trial -
[14C]-benzo[a]pyrene
NORTHWEST BIOTHERAPEUTICS INC
Environmental Exposure
3 trials -
[14C]-olinciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[14C]-praliciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[18F]-Ξ±vΞ²6-BP
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
[18F]FP-R01-MG-F2
PLIANT THERAPEUTICS, INC.
Idiopathic Pulmonary Fibrosis
1 trial -
[203Pb]VMT-Ξ±-NET
Perspective Therapeutics
Neuroendocrine Tumor Grade 2
1 trial -
[203Pb]VMT01
Perspective Therapeutics
Melanoma (Skin)
1 trial -
[212Pb] VMT-Ξ±-NET
Perspective Therapeutics
Neuroendocrine Tumors
1 trial -
[225Ac]Ac-AKY-1189 (therapeutic)
Aktis Oncology
Urothelial Carcinoma Bladder
1 trial -
[225Ac]Ac-AKY-2519 (therapeutic)
Aktis Oncology
Castration Resistant Metastatic Prostate Cancer
1 trial -
[68Ga]Ga-PentixaFor
CERO THERAPEUTICS HOLDINGS, INC.
triple-negative breast cancer
1 trial -
acetylsalicylic acid
United Therapeutics Europe Ltd
Precancerous Condition
1 trial -
acupuncture
United Therapeutics Europe Ltd
Migraine Headaches
1 trial -
administration of UI018
United Therapeutics Europe Ltd
Hyperlipemia, Mixed
1 trial -
administration of UI058
United Therapeutics Europe Ltd
GERD
1 trial -
administration of UI068
United Therapeutics Europe Ltd
Diabetes Mellitus, Type 2
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources